Rare diseases: No reason for lower demands for studies

23 octubre 2014

High-quality randomized controlled trials are also meaningful and feasible in rare diseases, experts say. For a different approach than in more common diseases, there are neither scientific reasons nor specific designs and methods that would not also be relevant for more common diseases. This is the case for both drug and non-drug treatments, they note.